These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10990121)

  • 1. Development of severe diabetic keto-acidosis with shock after changing interferon-beta into interferon-alpha for chronic hepatitis C.
    Hayakawa M; Gando S; Morimoto Y; Kemmotsu O
    Intensive Care Med; 2000 Jul; 26(7):1008. PubMed ID: 10990121
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.
    Soultati AS; Dourakis SP; Alexopoulou A; Deutsch M; Archimandritis AJ
    World J Gastroenterol; 2007 Feb; 13(8):1292-4. PubMed ID: 17451219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus during interferon therapy for chronic viral hepatitis.
    Mofredj A; Howaizi M; Grasset D; Licht H; Loison S; Devergie B; Demontis R; Cadranel JF
    Dig Dis Sci; 2002 Jul; 47(7):1649-54. PubMed ID: 12141831
    [No Abstract]   [Full Text] [Related]  

  • 5. Sudden onset of diabetic ketoacidosis during consensus interferon therapy for chronic viral hepatitis C.
    Nylen ES; Marathe IC; Khan IA; Azevedo R; Hirsch KR
    Am J Med Sci; 2008 Apr; 335(4):329-30. PubMed ID: 18414077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
    Lee YN; Jeong SW; Lim JH; Ryu YS; Jeon SR; Kim SK; Jang JY; Kim YS; Kim BS; Roh MO
    Korean J Hepatol; 2010 Jun; 16(2):187-91. PubMed ID: 20606504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy.
    Jabr FI; Ordinario MM
    Am J Med; 2003 Aug; 115(2):158-9. PubMed ID: 12893407
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes mellitus and interferon-alpha therapy.
    Murakami M; Iriuchijima T; Mori M
    Ann Intern Med; 1995 Aug; 123(4):318. PubMed ID: 7611607
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?
    Tosone G; Borgia G; Gentile I; Cerini R; Conte MC; Orlando R; Piazza M
    Acta Diabetol; 2007 Sep; 44(3):167-9. PubMed ID: 17721757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C.
    Gressens B; Gohy P
    Acta Gastroenterol Belg; 2004; 67(3):301-2. PubMed ID: 15587340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe anemia following combined alpha-interferon/ribavirin therapy of chronic hepatitis C.
    Tappero G; Ballaré M; Farina M; Negro F
    J Hepatol; 1998 Dec; 29(6):1033-4. PubMed ID: 9875657
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vogt-Koyanagi-Harada disease associated with interferon-alpha and ribavirin therapy for chronic hepatitis C infection].
    Chebil A; Kort F; Bouraoui R; Youssef NB; El Matri L
    J Fr Ophtalmol; 2010 Mar; 33(3):185-8. PubMed ID: 20172621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C.
    Nouri K; Busso M; Machler BC
    Cutis; 1997 Dec; 60(6):289-90. PubMed ID: 9426968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Various sarcoid lesions in a patient induced by interferon therapy for chronic hepatitis C.
    Noguchi K; Enjoji M; Nakamuta M; Sugimoto R; Kotoh K; Nawata H
    J Clin Gastroenterol; 2002 Sep; 35(3):282-4. PubMed ID: 12192210
    [No Abstract]   [Full Text] [Related]  

  • 15. Onset of coeliac disease during treatment with interferon for chronic hepatitis C.
    Cammarota G; Cuoco L; Cianci R; Pandolfi F; Gasbarrini G
    Lancet; 2000 Oct; 356(9240):1494-5. PubMed ID: 11081540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conception and pregnancy during interferon-alpha therapy for chronic hepatitis C.
    Trotter JF; Zygmunt AJ
    J Clin Gastroenterol; 2001 Jan; 32(1):76-8. PubMed ID: 11154177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
    Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
    Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Convulsive seizure during a treatment with interferon alpha for chronic viral hepatitis C].
    Verger P; De Monredon J; Blais J
    Gastroenterol Clin Biol; 1997; 21(11):902-3. PubMed ID: 9587549
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe exacerbation of asthma: a new side effect of interferon-alpha in patients with asthma and chronic hepatitis C.
    Bini EJ; Weinshel EH
    Mayo Clin Proc; 1999 Apr; 74(4):367-70. PubMed ID: 10221466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.